Section 1 Diabetes Mellitus 1. Definition and Epidemiology of Type 2 Diabetes Mellitus 2. Insulin Resistance: Pathophysiology, Molecular Mechanisms, Genetic Insights 3. Lifestyle Interventions for the Prevention of Type 2 Diabetes Mellitus 4. Pharmacological and Surgical Interventions That Prevent or Remit Type 2 Diabetes? 5. Type 1 Diabetes: Pathophysiology and Treatment Considerations for Cardiovascular Risk and Disease Section 2 Cardiovascular Complications of Type 2 Diabetes 6. Atherosclerosis in Patients with Type 2 Diabetes: Epidemiology 7. Pathology and Vascular Biology of Atherosclerosis in Patients with Type 2 Diabetes: Inflammation, Dyslipidemia, Hypercoagulability, Endothelial Dysfunction, and Inflammation 8.
Risk Stratification Among Patients with Type 2 Diabetes with or at Risk for Atherosclerotic Cardiovascular Disease 9. Epidemiology and Pathophysiology of Heart Failure with Preserved and with Reduced Ejection Fraction in Patients with Type 2 Diabetes Section 3 Effects of Antihyperglycemic Therapies for Type 2 Diabetes on Cardiovascular and Kidney Outcomes 10. Effect of Acute and Chronic Glucose Management on Coronary Heart Disease Risk in Patients with Type 2 Diabetes 11. Regulatory Approach to Medications for Type 2 Diabetes: Past, Present and Future 12. Cardiovascular and Kidney Effects of Sodium Glucose Co-transporter Inhibitors 13. Cardiovascular and Kidney Effects of Glucagon-like Peptide 1 Receptor Agonists 14. Antihyperglycemic Medications with Proven Cardiovascular Safety 15. Prevention of Heart Failure in Patients with Type 2 Diabetes 16.
Treatment of Patients with Reduced and with Preserved Ejection Fraction Heart Failure in Patients with Type 2 Diabetes Section 4 Management of Coronary Heart Disease Risk, Chronic and Acute Coronary Syndromes in Patients with Type 2 Diabetes 17. Effect of Lifestyle Interventions on Coronary Heart Disease Risk in Patients with Type 2 Diabetes 18. Effect of Blood Pressure Management on Coronary Heart Disease Risk in Patients with Type 2 Diabetes 19. Effect of Lipid Management on Coronary Heart Disease Risk in Patients with Type 2 Diabetes 20. Effect of Antiplatelet and Anticoagulant Therapies on Coronary Heart Disease Risk in Patients with Type 2 Diabetes 21. Therapeutic Implications of Type 2 Diabetes for Patients Undergoing Percutaneous or Surgical Coronary Revascularization 22. Epidemiology of Acute Coronary Syndromes in Patients with Type 2 Diabetes 23. Antiplatelet and Anticoagulant Therapy in Patients with Type 2 Diabetes with Acute Coronary Syndromes and/or Percutaneous Coronary Intervention Section 5 Other Cardiovascular Considerations Associated with Type 2 Diabetes 24.
Peripheral Artery Disease in Patients with Type 2 Diabetes 25. Cerebrovascular Disease in Patients with Type 2 Diabetes 26. Atrial Fibrillation in Patients with Type 2 Diabetes 27. Chronic Kidney Disease: Implications for Cardiovascular Risk and Management in Patients with Type 2 Diabetes 28. Disparities in Type 2 Diabetes Risk, Cardiovascular Consequences, and Care: Women, Race/Ethnic Minorities, and the Elderly 29. The Quality Chasm - Type 2 Diabetes.